Biotech · Private company
LimFlow, Inc.
Track this companyFree. Adds LimFlow, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- LimFlow Stent Graft SystemCritical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
- LimFlow SystemCritical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaNA · RECRUITING · started Dec 22, 2022ClinicalTrials.gov NCT05313165 · fetched Nov 12, 2026
- Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI StudyCOMPLETED · started Feb 24, 2020ClinicalTrials.gov NCT04304105 · fetched Nov 12, 2026
- PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaNA · UNKNOWN · started Dec 6, 2019ClinicalTrials.gov NCT03970538 · fetched Nov 12, 2026
- PROMISE I Early Feasibility Trial of the LimFlow Stent Graft SystemNA · COMPLETED · started Jul 5, 2017ClinicalTrials.gov NCT03124875 · fetched Nov 12, 2026